Difference between revisions of "Pharm Tech Minutes 2010.12.20"
Jump to navigation
Jump to search
(2 intermediate revisions by the same user not shown) | |||
Line 15: | Line 15: | ||
* Stephen Chu, NeHTA, Australia | * Stephen Chu, NeHTA, Australia | ||
+ | |||
+ | * Leonidas Tzimis, EAHP, Greece | ||
==Comments processed== | ==Comments processed== | ||
Line 43: | Line 45: | ||
* NeHTA Australia | * NeHTA Australia | ||
− | ===on HMW ( | + | ===on HMW === |
+ | |||
+ | * Jose Costa Teixeira (on spec. section 4.3.1) | ||
+ | |||
+ | Discussion on 'dispense' / allocate / assign / supply / deliver / distribute | ||
− | * | + | * Frank Oemig |
Latest revision as of 17:07, 20 December 2010
Participant list
- Jürgen Brandstätter, CodeWerk, Austria
- Jacqueline Surugue, EAHP, France
- Jose Costa Teixeira, Agfa Healthcare
- Marc Robberecht, Agfa Healthcare
- Simon Letellier, EAHP, France
- Viktor Hafner, Austria
- Stephen Chu, NeHTA, Australia
- Leonidas Tzimis, EAHP, Greece
Comments processed
GoTo Meeting TCon Dec 20., 2010, 21:00 – 23:00 (UTC+1)
on CMPD
- Siemens
IHE Pharmacy group can't wait 2 years for the release of CDAv3.
Important characteristics of CDAv2 are :
- persistance of information
- authentication
This also a requirement : so we use it.
We ackowledge that CDA is NOT intended to manage the workflow,
which will be managed using XDW profile.
on Common part (second part)
- NeHTA Australia
on HMW
- Jose Costa Teixeira (on spec. section 4.3.1)
Discussion on 'dispense' / allocate / assign / supply / deliver / distribute
- Frank Oemig